• Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Consensus Recommendation of "Moderate Buy" from Analysts

    Source: Buzz FX / 13 Jan 2025 11:45:17   America/Chicago


    Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Consensus Recommendation of "Moderate Buy" from Analysts Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Vir Biotechnology, Inc. ( NASDAQ:VIR - Get Free Report ) has been
    Read more...
Share on,